4.6 (291) · $ 19.00 · In stock
Familiarize yourself with KADCYLA® (ado-trastuzumab emtansine) preparation and storage in HER2+ early breast cancer. See Full Safety and Boxed Warnings for more information.
Trastuzumab - wikidoc
Herceptin (Trastuzumab): Side Effects, Uses, Dosage, Interactions
Conjugated Monoclonal Antibodies Market Share, Trends, Industry
WO2015164665A1 - Methods of treating early breast cancer with
Trastuzumab (Intravenous) Including Biosimilars of Trastuzumab
PDF) Mechanisms of resistance to trastuzumab emtansine (T-DM1) in
Antibody-Drug Conjugates in the Treatment of Breast Cancer
Ado-trastuzumab emtansine (Kadcyla) Drug Information
Antibody-Drug Conjugates (ADCs) in Oncology- Competitive Landscape
Treatment Schedule for EBC KADCYLA® (ado-trastuzumab emtansine)
HER-2 directed therapy in advanced breast cancer
What is KADCYLA® (ado-trastuzumab emtansine) for EBC?